Radiopharmaceutical Market, Nephrology, Neurology, and Immunology - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
Radiopharmaceutical Market: Segmentation
Based
on radioisotope, the market has been segmented into Technetium-99,
Lutetium-177, Rubidium-87, Iodine-123, Yttrium-90, and Gallium-62.
Technetium-99 is the most widely used radioisotope across the globe; around
70% of radiopharmaceutical companies depend on Mo-99 to produce Technetium-99,
as per the World Nuclear Association. The market segments have been
analyzed based on available approved products, cost-effectiveness, and
preference for technological systems by physicians and patients. The market size
and forecast for each of these segments have been provided for the period from
2014 to 2024, along with their respective CAGRs for the forecast period from
2016 to 2024, considering 2015 as the base year.
Based
on source, the radiopharmaceutical market has been segmented into two major
categories: nuclear reactors and cyclotrons. The market segments have been
extensively analyzed based on increase in demand for radioisotopes for nuclear
medicines, availability of radioisotopes and raw materials, radioisotopes short
half-life and number of production units used for production of radioisotopes.
Different types of end-user utilize radiopharmaceutical products to treat
diseases either through imaging techniques or the therapeutics method.
To read more please visit http://www.prnewswire.com/news-releases/radiopharmaceutical-market-nephrology-neurology-and-immunology---global-industry-analysis-size-share-growth-trends-and-forecast-2016---2024-300376969.html
Source: PR Newswire